References
- Pharmaceuticals_China.pdf [Internet]. 2016. [cited 2020 Sep 8]. Available from: https://legacy.trade.gov/topmarkets/pdf/Pharmaceuticals_China.pdf.
- Global Health Expenditure Database [Internet]. 2020. [cited 2020 Sep 8]. Available from: https://apps.who.int/nha/database.
- China’s FDA becomes a member of ICH. [cited 2020 Oct 7]. Available from: https://connect.dcat.org/blogs/regulatory-news/2017/06/29/chinas-fda-becomes-a-member-of-ich#.X-nX1dgzbIV
- Ni J, Zhao J, Ung COL, et al. Obstacles and opportunities in Chinese pharmaceutical innovation. Global Health. 2017;13(1):21–21.
- Woolley KL, Sun P. The yin and yang of medical writing in China. MEW. 2013;22:83–89.
- Sismondo S. Ghosts in the machine: publication planning in the medical sciences. Soc Stud Sci. 2009;39(2):171–198.
- Jacobs A, Wager E. European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin. 2005;21(2):317–322.
- Fugh-Berman AJ. The haunting of medical journals: how ghostwriting sold “ "HRT". PLoS Med. 2010;7(9):e1000335.
- Seehusen DA, Koren KG. Impact of industry sponsorship on research outcomes. Am Fam Physician. 2013;88:746–746.
- Lundh A, Lexchin J, Mintzes B, et al. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2017;2:MR000033.
- Foster C, Steere J, Sullivan L, et al. Current and future publication practices: a survey of attendees at ISMPP 2010. Curr Med Res Opin 27: S8.
- AMWA Code of Ethics - American Medical Writers Association [Internet]. [cited 2020 Oct 23]. Available from: https://www.amwa.org/page/Code_of_Ethics.
- Hamilton S, Bernstein AB, Blakey G, et al. Developing the Clarity and Openness in Reporting: E3-based (CORE) Reference user manual for creation of clinical study reports in the era of clinical trial transparency. Res Integr Peer Rev. 2016;1:4.
- Core practices | COPE: Committee on Publication Ethics [Internet]. 2018. [cited 2020 Oct 23]. Available from: https://publicationethics.org/core-practices.
- Mazov NA, editor. CSE’s white paper on promoting integrity in scientific journal publications; 2012. Update [Internet]. Ural University Press; 2016. [cited 2020 Oct 23]. Available from: http://academy.rasep.ru/images/documents/rukovodstva/White%20Paper_DOI_Rus.pdf.
- The EQUATOR Network | Enhancing the QUAlity and transparency of health research [Internet]. 2020. [cited 2020 Oct 23]. Available from: https://www.equator-network.org/.
- EMWA, AMWA, ISMPP. AMWA-EMWA-ISMPP joint position statement on the role of professional medical writers. MEW. 2017;26:7–8.
- Battisti WP, Wager E, Baltzer L, et al. Good publication practice for communicating company-sponsored medical research: GPP3. Ann Intern Med. 2015;163(6):461–464.
- Clark J, Gonzalez J, Mansi B, et al. Enhancing transparency and efficiency in reporting industry-sponsored clinical research: report from the Medical Publishing Insights and Practices initiative. Int J Clin Pract. 2010;64(8):1028–1033.
- Chipperfield L, Citrome L, Clark J, et al. Authors' Submission Toolkit: a practical guide to getting your research published. Curr Med Res Opin. 2010;26(8):1967–1982.
- Mansi BA, Clark J, David FS, et al. Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective. Mayo Clin Proc. 2012;87(5):424–429.
- Maruš.Ić A, Hren D, Mansi B, et al. Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications. BMC Med. 2014;12:197.
- Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective | The BMJ [Internet]. 2016. [cited 2020 Oct 23]. Available from: https://www.bmj.com/content/355/bmj.i5078/rapid-responses.
- Hesp BR, Arai K, Chu MYS, et al. A guide to applying the Good Publication Practice 3 guidelines in the Asia-Pacific region. Res Integr Peer Rev. 2019;4:21.
- Rohwer A, Young T, Wager E, et al. Authorship, plagiarism and conflict of interest: views and practices from low/middle-income country health researchers. BMJ Open. 2017;7(11):e018467.
- Stretton S, Bramich NJ, Keys JR, et al. Publication misconduct and plagiarism retractions: a systematic, retrospective study. Curr Med Res Opin. 2012;28(10):1575–1583.
- Qi X, Deng H, Guo X. Characteristics of retractions related to faked peer reviews: an overview. Postgrad Med J. 2017;93(1102):499–503.
- Wager E, Woolley K, Adshead V, et al. Awareness and enforcement of guidelines for publishing industry-sponsored medical research among publication professionals: the Global Publication Survey. BMJ Open. 2014;4(4):e004780.
- Woolley KL, Dickson T, Seth A, et al. The Certified Medical Publication Professional (CMPPTM) credential: more than a knowledge test? Poster presented at ISMPP US Meeting; 2015 Apr; Arlington, VA. [cited 2020 Oct 7]. Available from: https://www.ismpp.org/assets/docs/Education/AnnualMeeting/11thAM/General_Session/Tuesday/cmpp_parallel_final.pdf
- Hamilton CW, Jacobs A. Ghostwriting prevalence among AMWA and EMWA members (2005 to 2014). MEW. 2016;25:6–14.
- Sharma S. How to become a competent medical writer? Perspect Clin Res. 2010;1(1):33–37.
- Global scientific output doubles every nine years: News blog [Internet]. 2014. [cited 2020 Sep 25]. Available from: http://blogs.nature.com/news/2014/05/global-scientific-output-doubles-every-nine-years.html.
- Wager E. Publishing clinical trial results: the future beckons. PLoS Clin Trials. 2006;1(6):e31.
- Pakes GE. Writing manuscripts describing clinical trials: a guide for pharmacotherapeutic researchers. Ann Pharmacother. 2001;35(6):770–779.
- Li X, Tao K, Zhou Q, et al. Endorsement of the CONSORT statement by high-impact medical journals in China: a Survey of Instructions for authors and published papers. PLOS One. 2012;7(2):e30683.
- Huang W, Wang W, Zhan J, et al. Scientific publications in ophthalmic journals from China and other top-ranking countries: a 12-year review of the literature. BMC Ophthalmol. 2013;13(1):25.
- Liu X-Y, Wan X-H, Li Z-W. Ten-year survey on oncology publications from China and other top-ranking countries. Chin Med J (Engl). 2011;124(20):3314–3319.
- Scherer RW, Ugarte-Gil C, Schmucker C, et al. Authors report lack of time as main reason for unpublished research presented at biomedical conferences: a systematic review. J Clin Epidemiol. 2015;68(7):803–810.
- Duracinsky M, Lalanne C, Rous L, et al. Barriers to publishing in biomedical journals perceived by a sample of French researchers: results of the DIAzePAM study. BMC Med Res Methodol. 2017;17:96. [cited 2020 Sep 25]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504731/.
- Das N, Das S. Knowledge and attitudes of Indian surgeons regarding professional medical writing support. Perspect Clin Res. 2018;9(3):127–132.
- Norris R, Bowman A, Fagan JM, et al. International Society for Medical Publication Professionals (ISMPP) position statement: the role of the professional medical writer. Curr Med Res Opin. 2007;23(8):1837–1840.
- Chang C. The medical writing landscape in China. MEW. 2019;28:70–73.